Suchergebnisse - "Chikungunya"

PubPharm (4.157)

1

Sylvatic Transmission of Zika, Dengue, and Chikungunya Viruses in Thailand and Cambodia : Investigating the Sylvatic Transmission and Reservoir Potential of Zika, Dengue, and Chikungunya Viruses of Co-located Humans and Long-tailed Macaques of Thailand and Cambodia

enthalten in: ClinicalTrials.gov | 2024

2

A Clinical Phase 3 Study of VLA1553 in Adult Participants With Human Immunodeficiency Virus (HIV) : An Open-label Phase 3 Study to Assess the Safety and Immunogenicity of a Live-attenuated Chikungunya Virus Vaccine Candidate (VLA1553) in Moderately Immunocompromised Adult Participants Infected With Human Immunodeficiency Virus

enthalten in: ClinicalTrials.gov | 2024

3

Analysis of spatial and demographic factors associated with chikungunya in Espírito Santo state, Brazil

enthalten in: Transactions of the Royal Society of Tropical Medicine and Hygiene | 2024

von Clipes, M. | Vicente, C. | Cardoso da Silva, T. | +2

4

Phase 1 Study of SAR440894 vs Placebo : A Phase 1, Randomized, Double-Blind, Multi-Site, Single Dose Escalation Study to Evaluate the Safety, Pharmacokinetics, and Immunogenicity of SAR440894 vs Placebo in Healthy Adults

enthalten in: ClinicalTrials.gov | 2024

5

Genomic and eco-epidemiological investigations in Uruguay reveal local Chikungunya virus transmission dynamics during its expansion across the Americas in 2023

enthalten in: Emerging microbes & infections | 2024

von Burgueño, A. | Giovanetti, M. | Fonseca, V. | +15

UpdateOf: medRxiv. 2023 Aug 20;:. - PMID 37646000

6

Awareness and Knowledge of Chikungunya Virus Infection Among Healthcare Workers in Hulu Langat District

enthalten in: Asia-Pacific journal of public health | 2024

von Selamat, U. | Hairi, N. | Suli, Z.

7

Cytokine storm in Chikungunya : Can we call it multisystem inflammatory syndrome associated with Chikungunya?

enthalten in: Reumatologia clinica | 2024

von Morel, Z. | Martínez, T. | Galeano, F. | +7

8

A Phase 2 Clinical Study of VLA1553 in Healthy Children Aged 1 to 11 Years : A Randomized, Observer-blinded, Dose Response Phase 2 Trial to Assess the Safety and Immunogenicity of Two Different Dose Levels of a Live-attenuated Chikungunya Virus Vaccine (VLA1553) in Healthy Children Aged 1 to 11 Years

enthalten in: ClinicalTrials.gov | 2024

9

Arbovirus - a threat to transfusion safety in Spain : a narrative review

enthalten in: Medicina clinica | 2024

von Giménez-Richarte, �. | Arbona Castaño, C. | Ramos-Rincón, J.

10

Arctigenin from Arctium lappa L. inhibits chikungunya virus by affecting its entry and replication

enthalten in: Phytomedicine : international journal of phytotherapy and phytopharmacology | 2024

von Shukla, S. | Kakade, M. | Cherian, S. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[416]